Наша группа организует более 3000 глобальных конференций Ежегодные мероприятия в США, Европе и США. Азия при поддержке еще 1000 научных обществ и публикует более 700 Открытого доступа Журналы, в которых представлены более 50 000 выдающихся деятелей, авторитетных учёных, входящих в редколлегии.
Журналы открытого доступа набирают больше читателей и цитируемости
700 журналов и 15 000 000 читателей Каждый журнал получает более 25 000 читателей
Logan Kshatriya
Renal Cell Carcinoma is a common form of kidney cancer that traditionally required radical nephrectomy, the complete removal of the affected kidney. However, recent advancements in medical science and surgical techniques have paved the way for renal preservation therapy, also known as nephron-sparing surgery or partial nephrectomy. This revolutionary approach aims to preserve kidney function while effectively treating the cancer. This article provides an overview of renal preservation therapy, highlighting its advantages such as kidney function preservation, minimized surgical complications, enhanced oncological outcomes, and expanded future treatment options. The various surgical techniques and advancements in imaging technology are discussed, along with considerations for patient selection. Renal preservation therapy represents a significant breakthrough in RCC treatment, offering improved quality of life and reduced long-term complications for patients.